BioGaia
116.90 SEK
-4.02 %
Less than 1K followers
BIOG B
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-4.02 %
+4.66 %
+10.08 %
+10.08 %
+9.56 %
+1.92 %
+27.52 %
+43.08 %
+1,545.71 %
BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.
Read moreMarket cap
11.83B SEK
Turnover
12.27M SEK
Revenue
1.54B
EBIT %
26.82 %
P/E
35.53
Dividend yield-%
3.42 %
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
7/5
2026
General meeting '26
7/5
2026
Interim report Q1'26
8/5
2026
Bonus dividend
All
Webcasts
Press releases
ShowingAll content types
Kallelse till årsstämma i BioGaia AB (publ)
BioGaias Års- och hållbarhetsredovisning 2025 publicerad
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
